Tag: cardiotoxicity

HF Med Cornucopia Center Stage in Upcoming ESC Guideline: Preview

Today there are so many evidence-based drug therapies for heart failure (HF) with reduced ejection fraction (HFrEF) that physicians treating HF patients almost don’t know...

Zanubrutinib Better Than Ibrutinib in CLL/SLL?

Zanubrutinib (Brukinsa), a second-generation Bruton tyrosine kinase (BTK) inhibitor, has shown a significantly greater delay in disease progression vs the standard of care ibrutinib (Imbruvica)...

New Data Strengthen Case for Prechemotherapy Statins

Evidence supporting the use of statins to protect against cardiotoxic chemotherapy has been strengthened with new data from a propensity-matched analysis. Among women with breast...

Slow Taper off Antimalarial Avoids Lupus Flare During Remission

Slowly tapering off – or remaining on – antimalarial medications can help prevent disease flare in patients with systemic lupus erythematosus (SLE) who’ve achieved clinical...